<DOC>
	<DOCNO>NCT01683253</DOCNO>
	<brief_summary>The purpose study see whether ICDs ( Impulse Control Disorder ) improve neuropsychiatric trait relate ICD change switch dopamine agonist levodopa/carbidopa patient Parkinson 's disease treat dopaminergic medication .</brief_summary>
	<brief_title>Remission ICD Switching Dopamine Agonist Levodopa/Carbidopa</brief_title>
	<detailed_description>- PRIMARY OBJECTIVE To evaluate improvement mMIDI ( modify version Minnesota Impulsive Disorders Interview , Korean version ) score baseline 12 week LOCF ( Last Observation Carried Forward ) - SECONDARY OBJECTIVE ) To evaluate improvement neuropsychiatric profile baseline 12 week LOCF ii ) To evaluate improvement UPDRS ( Unified Parkinson 's Disease Rating Scale ) Score baseline 12 week LOCF</detailed_description>
	<mesh_term>Disruptive , Impulse Control , Conduct Disorders</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Carbidopa</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Patient diagnosis idiopathic PD accord United Kingdom Parkinson 's Disease Brain Bank Criteria mMIDI ≥ 3 score ICD Patients must antiparkinson treatment least 6 month screen . protocol , dopamine agonist include his/her antiparkinson treatment . 30years ≤ patient &lt; 80years age , male female patient must give write informed consent assessment perform Requirement treatment serious cognitive disorder , behavioral disorder , mental illness currently future patient ≤ 65years : KMMSE ( korean version MiniMental State Exam ) ≤24 , patient ≥ 66years : KMMSE ≤ 20 , patient dementia ( incl . early dementia ) even though KMMSE score 20 Requirement treatment 6times per day due severe motor fluctuation . Severe dyskinesia DBS ( Deep Brain Stimulation ) surgical treatment History melanoma notdiagnostic skin trouble/skin lesion narrow angle glaucoma clinically serious surgical medical condition malignant tumor use investigational drug time enrollment within 4weeks pregnant , nurse lactate woman woman childbearing potential history hypersensitivity allergy levodopa/carbidopa serious disease accordidng investigator 's discretion</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>